US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.64

+0.41441.21%

Volume:3K

Turnover:89.34K

Market Cap:44.17M

PE:- -

High:34.64

Open:34.48

Low:34.41

Close:34.23

52wk High:35.61

52wk Low:27.50

Shares:1.28M

Float Shares:1.28M

Volume Ratio:0.76

T/O Rate:0.20%

Dividend:0.08

Dividend Rate:0.22%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS

Ascendis Pharma Price Target Maintained with a $345.00/Share by HC Wainwright & Co.

BioMarin to receive 20% royalty on net sales of Yuviwel from Ascendis Pharma

Biomarin Pharmaceutical Shares up 5.6% Premarket After Co Announces Global Settlement with Ascendis Pharma

THOMSON REUTERS

BioMarin Settles Patent Lawsuits With Ascendis Pharma Over Yuviwel

MT Newswires Live

Biomarin Pharmaceutical - to Dismiss Itc Investigation; All Ip Claims Resolved Including Litigation in Multiple Countries

THOMSON REUTERS

Will Japan’s First IMCIVREE Approval in Hypothalamic Obesity Change Rhythm Pharmaceuticals’ (RYTM) Narrative

Simply Wall St.

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live

Rhythm Pharmaceuticals Initiated at Hold by Deutsche Bank

Rhythm Pharmaceuticals, Inc. : Deutsche Bank Initiates Coverage with Hold Rating and Target Price $120

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/MEDI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","market":"US","secType":"STK","nameCN":"HARBOR HEALTH CARE ETF","latestPrice":34.6411,"timestamp":1788379200000,"preClose":34.2267,"halted":0,"volume":2590,"delay":0,"changeRate":0.012107506712595738,"floatShares":1275000,"shares":1275000,"eps":0,"marketStatus":"Pre-Mkt","change":0.4144,"latestTime":"09-03 05:01:32 EDT","open":34.475,"high":34.6411,"low":34.41,"amount":89336,"amplitude":0.006752,"askPrice":41.04,"askSize":100,"bidPrice":13.93,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.6411,"sharesOutstanding":925000,"nav":34.25536,"aum":43675584.08,"dividendRate":0.002179,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.5,"preClose":34.6411,"latestTime":"16:10 EDT","volume":8,"amount":277.1288,"timestamp":1788379804895,"change":-0.1411,"changeRate":-0.004073,"amplitude":0},"volumeRatio":0.755630757640152},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","floatShares":1275000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.755630757640152,"shares":1275000,"dividePrice":0.0755,"high":34.6411,"amplitude":0.006752,"preClose":34.2267,"low":34.41,"week52Low":27.5,"pbRate":"--","week52High":35.605,"institutionHeld":0,"latestPrice":34.6411,"eps":0,"divideRate":0.002179,"volume":2590,"delay":0,"ttmEps":0,"open":34.475,"prevYearClose":31.45,"prevWeekClose":33.91,"prevMonthClose":34.24,"prevQuarterClose":33.84,"fiveDayClose":34.59,"twentyDayClose":32.8671,"sixtyDayClose":30.3888},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDI\",params:#limit:5,,,undefined,":[{"date":"2025-12-19","symbol":"MEDI","amount":0.07515,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-24"},{"date":"2024-12-20","symbol":"MEDI","amount":0.13455,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"MEDI","amount":0.4613,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"HARBOR HEALTH CARE ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDI\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.4613,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-26","value":0.13455,"currency":"USD"},{"executeDate":"2025-12-19","recordDate":"2025-12-19","paymentDate":"2025-12-24","value":0.07515,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDI\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663107253","title":"Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2663107253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663107253?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:45","pubTimestamp":1788173100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUAC43G7H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0787776722.HKD","IE00BFTCPJ56.SGD","LU1551013342.USD","TMED","BK4599","LU2089283258.USD","IE00B1BXHZ80.USD","LU2456880835.USD","LU0689472784.USD","IE0004445239.USD","LU2023250330.USD","LU2168563687.JPY","IE00BJJMRZ35.SGD","LU0158827948.USD","LU2357305700.SGD","LU0109391861.USD","LU0079474960.USD","LU1868836591.USD","LU2896262040.SGD","IE00BK4W5M84.HKD","LU1551013425.SGD","XLV","IE0002141913.USD","IHE","LU0094547139.USD","LU0114720955.EUR","LU0432979614.USD","IE00B2B36J28.USD","LU2360106947.USD","LU0289739699.SGD","SG9999014898.SGD","BK4007","LU1917777945.USD","LU1720051108.HKD","LU2471134796.USD","LU2552382132.HKD","LU0096364046.USD","LU0097036916.USD","LU2237443382.USD","LU0174119429.USD","LU2468319806.SGD","LU0823416689.USD","IE00BFSS8Q28.SGD","LU2237443978.SGD","HRTS","LU0672654240.SGD","LU2168564495.EUR","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","LU0354030438.USD","LU2213496289.HKD","LLYZ","LU0471298777.SGD","IE00B775H168.HKD","GDOC","LU2361044865.SGD","LU1868836757.USD","THNR","LU2756315664.SGD","LU0210536198.USD","IE00BKPKM429.USD","LU0203201768.USD","LU1061106388.HKD","LU2237443622.USD","LU1629891620.HKD","IXJ","LU1232071149.USD","LU2746668974.SGD","SG9999017495.SGD","LU1280957306.USD","LU0198837287.USD","LU0786609619.USD","SGXZ81514606.USD","VHT","LU2750360641.GBP","LU2063271972.USD","LU2089984988.USD","JDOC","IE00BJLML261.HKD","SG9999018857.SGD","AGNG","LU2087625088.SGD","LU0882574139.USD","LU0256863811.USD","SG9999001176.SGD","LU0708995401.HKD","LU2361044949.HKD","LU2089284900.SGD","LU2168564222.USD","LU1868837300.USD","SG9999018865.SGD","SG9999014880.SGD","LU2462591350.SGD","LU0471298694.HKD","CANC","LU0225283273.USD","LU1804176565.USD","LU0820561909.HKD","LU1035775433.USD","IE00B4JS1V06.HKD","SG9999015986.USD","BK4516","LU0106261372.USD","LU0122379950.USD","LU2750360997.AUD","LU1691799644.USD","LU2746668461.USD","LU1623119135.USD","LU0058720904.USD","LU1979441026.SGD","SG9999014906.USD","SGXZ31699556.SGD","IE00BWXC8680.SGD","SG9999014914.USD","LU2108987350.USD","ELIS","LU0320765059.SGD","LU1814569148.SGD","ELIL","LU2211815571.USD","LU2491050071.SGD","LU2602419157.SGD","IE0005OL40V9.USD","LU1868836914.USD","IE0009355771.USD","LU0158827781.USD","LU2361045086.USD","LU1093756325.SGD","LU0109394709.USD","LU0417517546.SGD","LU1366192091.USD","LU1267930730.SGD","LU2324357040.USD","FHLC","BK4588","BK4585","LU1974910355.USD","LU0943347566.SGD","SG9999015952.SGD","CURE","LU0882574055.USD","SG9999015945.SGD","IE00B7KXQ091.USD","LU0683600562.USD","LU2471134952.CNY","LU2237443895.HKD","LU0820561818.USD","LU1291159041.SGD","LU1064131342.USD","LU1720051017.SGD","LU2237443549.SGD","LU1983299246.USD","PPH","LU0266013472.USD","LLII","GB00BDT5M118.USD","IYH","LU1323610961.USD","LU0353189763.USD","IE00BK4W5L77.USD","LU0964807845.USD","LU2023250504.SGD","LU0256863902.USD","BK4533","LU0320765992.SGD","LU0345770308.USD","LU1057294990.SGD","LU2491049909.HKD","LLY","LU2028103732.USD","LU2111349929.HKD","LU1548497426.USD","IE00BJJMRX11.SGD","SG9999013999.USD","TRUH","LU2106854487.HKD","ILDR","SGXZ57979304.SGD","LU2265009873.SGD","IE0004445015.USD","LU2471134879.HKD","LU1989771016.USD","LU2168564065.EUR","IE00BKDWB100.SGD","LU0889565916.HKD","PJP","LU0820562030.AUD","SG9999001176.USD","LLYX","SGXZ99366536.SGD","LU1868837136.USD","IE00BJJMRY28.SGD","LU2264538146.SGD","LU0466842654.USD","FTXH","LU0385154629.USD","LU0316494557.USD","LU0354030511.USD","LU2491050154.USD","LU0203202063.USD","LU2271345857.HKD","LU2112291526.USD","IE0001KFT4U8.USD","RXL","OZEM","LU0640476718.USD","LU2023251221.USD","LU2168564149.EUR","LU0353189680.USD","SGXZ51526630.SGD","MEDX","LU2461242641.AUD","LU0345770993.USD","LU2471134523.USD","IE00B1XK9C88.USD","LU2237443465.HKD","LU1712237335.SGD","LU1127390331.HKD","LU0456855351.SGD","LU2462157665.USD","LU1069344957.HKD","LU2236285917.USD","LU2552382058.USD","LU2756315318.SGD","LU0823434740.USD","SG9999015978.USD","BK4581","LU1145028129.USD","LU1023059063.AUD","LU1093756168.USD","LU2237438978.USD","IE00B4R5TH58.HKD","BK4534","LU0823434583.USD","IE00BN29S564.USD","LU0006306889.USD","LU0238689110.USD","LU0234572021.USD","LU2417539215.USD","LU1988902786.USD","LU2552382215.SGD","LU0133085943.USD","LU0323591593.USD","MEDI","MHIP","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072509","title":"Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663072509?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:45","pubTimestamp":1788173100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUAC43G7H:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","LU2089984988.USD","IXJ","LU1988902786.USD","LU0266013472.USD","LU0210536198.USD","LU2468319806.SGD","LU2756315318.SGD","MEDX","LU0820562030.AUD","LU1814569148.SGD","LU0943347566.SGD","LU1280957306.USD","LU0354030511.USD","LU2236285917.USD","LU0640476718.USD","SG9999015978.USD","IE00B7KXQ091.USD","LU2361044865.SGD","LU1127390331.HKD","BK4585","LU2063271972.USD","LU0323591593.USD","LU0353189680.USD","LU1868836914.USD","LU0823416689.USD","FTXH","IE00B4JS1V06.HKD","LU0094547139.USD","LU2357305700.SGD","SG9999001176.USD","LU2896262040.SGD","SG9999014914.USD","IE00B4R5TH58.HKD","LU2168564065.EUR","LU1691799644.USD","LU1720051108.HKD","LU2213496289.HKD","LU2271345857.HKD","SG9999013999.USD","LU1868837300.USD","IE00BKPKM429.USD","LU0786609619.USD","LU1983299246.USD","LU2108987350.USD","LU1551013425.SGD","LU2746668974.SGD","SG9999015945.SGD","SGXZ57979304.SGD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU0456855351.SGD","HRTS","LU2087625088.SGD","VHT","AGNG","LU0417517546.SGD","BK4007","LU0096364046.USD","LU0471298694.HKD","LU2265009873.SGD","LU1868837136.USD","LU2111349929.HKD","LU2360106947.USD","LU2324357040.USD","IE00BK4W5M84.HKD","LU0234572021.USD","LU0708995401.HKD","IE00B1XK9C88.USD","LU0820561909.HKD","SG9999014880.SGD","LU0787776722.HKD","LU0006306889.USD","LU0256863902.USD","RXL","LU1323610961.USD","GB00BDT5M118.USD","LU2237443978.SGD","LU0882574139.USD","LU1623119135.USD","LU2211815571.USD","LU0109394709.USD","IE0009355771.USD","JDOC","LU0158827948.USD","LU1551013342.USD","LU2746668461.USD","LU2237443382.USD","LU0256863811.USD","LLYX","IE00BFTCPJ56.SGD","LU2456880835.USD","TMED","LU2237443622.USD","LU2237443549.SGD","LU0432979614.USD","LU0174119429.USD","LU2168564222.USD","LU1868836591.USD","LU1712237335.SGD","IHE","LU0058720904.USD","LU2237443465.HKD","BK4581","LU2552382058.USD","IE0001KFT4U8.USD","LU1917777945.USD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU0203202063.USD","LU1989771016.USD","LU1035775433.USD","LLY","LU2237438978.USD","LU0320765992.SGD","LU0225283273.USD","LU2552382215.SGD","IE0002141913.USD","LU2168563687.JPY","LU2756315664.SGD","LU0820561818.USD","LU0203201768.USD","LU2462591350.SGD","LU0158827781.USD","LU2028103732.USD","LU2602419157.SGD","LU0683600562.USD","IYH","LU2023250330.USD","OZEM","IE00BFSS8Q28.SGD","SGXZ51526630.SGD","LU0316494557.USD","LU0079474960.USD","LU1868836757.USD","LU2491050154.USD","LU1291159041.SGD","LU2471134796.USD","LU0672654240.SGD","LU2471134879.HKD","SG9999014906.USD","SGXZ31699556.SGD","BK4516","LU1979441026.SGD","IE00BWXC8680.SGD","LU1804176565.USD","IE0004445239.USD","IE00B1BXHZ80.USD","LU2237443895.HKD","LU1069344957.HKD","LU2361044949.HKD","BK4588","LU1093756168.USD","SG9999018857.SGD","LU0109391861.USD","ELIS","LU2471134523.USD","SG9999014898.SGD","IE00BJJMRZ35.SGD","FHLC","LU2023250504.SGD","THNR","LU0823434583.USD","LU0889565916.HKD","LU1267930730.SGD","LU0354030438.USD","LU2361045086.USD","LU2491049909.HKD","PJP","LU2023251221.USD","LU0320765059.SGD","LU2417539215.USD","SG9999015986.USD","LU0198837287.USD","LU0238689110.USD","LU2461242641.AUD","LU0133085943.USD","LU1629891620.HKD","ILDR","SG9999015952.SGD","LU0114720955.EUR","XLV","IE00BFSS7M15.SGD","LU2462157665.USD","SG9999001176.SGD","LU1145028129.USD","IE00BJLML261.HKD","LU1548497426.USD","LU0353189763.USD","BK4534","LU0882574055.USD","LU0385154629.USD","LU0823434740.USD","LU2168564495.EUR","LU2089283258.USD","BK4599","LLII","LU2264538146.SGD","LU1064131342.USD","SGXZ99366536.SGD","MEDI","LU1974910355.USD","LU1093756325.SGD","WDNA","LU0345770993.USD","LU0106261372.USD","MHIP","GDOC","LU0061475181.USD","IE0004445015.USD","LU0289739699.SGD","LU0964807845.USD","CANC","IE00BKDWB100.SGD","LU1232071149.USD","LU2750360641.GBP","LU2471134952.CNY","BK4533","LU0345770308.USD","LU2750360997.AUD","LU0097036916.USD","IE00BJJMRY28.SGD","IE0005OL40V9.USD","IE00B775H168.HKD","LU0466842654.USD","LU1720051017.SGD","TRUH","LU2491050071.SGD","IE00BN29S564.USD","ELIL","LU2168564149.EUR","LU2112291526.USD","LU2552382132.HKD","LU1061106388.HKD","LU2089284900.SGD","LU1023059063.AUD","CURE","LU2106854487.HKD","LU0122379950.USD","IE00BJJMRX11.SGD","LU0689472784.USD","SG9999017495.SGD","PPH","LU1057294990.SGD","LLYZ","LU1366192091.USD","LU0471298777.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072327","title":"Ascendis Pharma Price Target Maintained with a $345.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663072327?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:42","pubTimestamp":1788172920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ASND/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0109394709.USD","BK4139","LU0320765992.SGD","ASND","BK4585","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663294076","title":"BioMarin to receive 20% royalty on net sales of Yuviwel from Ascendis Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2663294076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663294076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:15","pubTimestamp":1788167708,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) announced that it has entered into binding terms with Ascendis Pharma (ASND), resolving the patent and ancillary disputes pending g...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarin-to-receive-20-royalty-on-net-sales-of-yuviwel-from-ascendis-pharma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarin-to-receive-20-royalty-on-net-sales-of-yuviwel-from-ascendis-pharma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0889565916.HKD","BK4566","USRD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BMRN","IE00B19Z3B42.SGD","MEDI","ASND","IE0002270589.USD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075865","title":"Biomarin Pharmaceutical Shares up 5.6% Premarket After Co Announces Global Settlement with Ascendis Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075865?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:36","pubTimestamp":1788165406,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S0MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE00B19Z3581.USD","MEDI","ASND","IE00B19Z3B42.SGD","LU0109394709.USD","LU0320765992.SGD","BMRN","LU0889565916.HKD","BK4585","IE0002270589.USD","BK4566","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076078","title":"BioMarin Settles Patent Lawsuits With Ascendis Pharma Over Yuviwel","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076078","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076078?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:53","pubTimestamp":1788162812,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical  said Monday it entered into a binding agreement to resolve all global patent disputes with Ascendis Pharma  concerning the drug Yuviwel used to treat linear growth failure.Ascendis will pay royalties of 20% on US net sales and 18% on sales in the European Union, Brazil, and South Korea through May 2030, the company said.The license covers all present and future uses of the treatment, including achondroplasia, BioMarin said.The deal terminates pending legal proceedings in the US, Germany, Denmark, Brazil, and South Korea, it added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMRN","IE00B19Z3581.USD","LU0109394709.USD","BK7095","MEDI","BK4585","IE00B7SZLL34.SGD","BK4139","IE0002270589.USD","LU0320765992.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","BMRN.AU","BK4566","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022409","title":"Biomarin Pharmaceutical - to Dismiss Itc Investigation; All Ip Claims Resolved Including Litigation in Multiple Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022409?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:00","pubTimestamp":1788156001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA7NTQQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0889565916.HKD","LU0320765992.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","ASND","BK4585","LU0109394709.USD","BMRN","IE00B19Z3581.USD","MEDI","BK4566","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021276","title":"Will Japan’s First IMCIVREE Approval in Hypothalamic Obesity Change Rhythm Pharmaceuticals’ (RYTM) Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021276","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021276?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:16","pubTimestamp":1788139015,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals has received marketing authorization in Japan for IMCIVREE (setmelanotide) to treat acquired hypothalamic obesity, the first approved therapy in that indication, supported by positive Phase 3 TRANSCEND data showing a statistically significant placebo-adjusted reduction in body mass index.\nThis approval opens a new rare-disease market in Japan, where Rhythm estimates 5,000 to 8,000 people live with acquired hypothalamic obesity, potentially expanding the company’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals/news/will-japans-first-imcivree-approval-in-hypothalamic-obesity","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals/news/will-japans-first-imcivree-approval-in-hypothalamic-obesity","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RYTM","BK4139","BK4588","BK4585","AIPO","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","BBP","IEIH","FRTY","LABU","XLVX","IYH","MEDI","MRNX","LFSC","IDNA","SYNB","RSPH","GDOC","GNMX","PTGX","TAK","IBB","BK4139","MRNY","BMED","PINK","BK4585","BK4007","NVIB","TBXU","BK4588","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","LU0114720955.EUR","LU1066051498.USD","LU1934455863.HKD","BK4578","BK4568","LU2468319806.SGD","BMED","LU0965508806.USD","MEDI","IE00B3T34201.USD","LU0234570918.USD","TBXU","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1023059063.AUD","LU1839511570.USD","LU1934455277.USD","LU2324357040.USD","BBH","BK4585","SG9999015945.SGD","IBB","GILD","LU0109394709.USD","LU0882574055.USD","LU1066053197.SGD","LU0823416689.USD","IE00BKVL7J92.USD","BK4583","IE00B19Z3B42.SGD","LU0965509283.SGD","LU1061106388.HKD","BIB","LU2112291526.USD","LU0122379950.USD","BK4532","LU1430594728.SGD","IBBQ","BK4550","TMED","BK4139","BK4588","SG9999015978.USD","LU1934455194.USD","LU1585245621.USD","LU1571399168.USD","LU0058720904.USD","LU2089984988.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019778","title":"Pharma Industry Stares Down Biggest Patent Cliff in Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019778?lang=en_us&edition=fundamental","pubTime":"2026-08-29 09:00","pubTimestamp":1787965200,"startTime":"0","endTime":"0","summary":"Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU2347655156.SGD","LU1496350502.SGD","LU2125154778.USD","NVOH","LU0158827948.USD","LU0029864427.USD","LU1571399168.USD","LU2417539215.USD","IE000MB6IJN5.SGD","IXJ","NVOC","IE00BK4W5M84.HKD","LU0234570918.USD","SG9999011175.SGD","LU0471298694.HKD","SG9999014567.USD","LU0471298777.SGD","LU1983299246.USD","LU1551013425.SGD","LU0965509010.AUD","IE00BJJMRY28.SGD","LU0211328371.USD","LU2023250843.SGD","BK4550","LU2456880835.USD","LU1814569148.SGD","LU0795875169.SGD","LU2357627491.SGD","BK4533","LU0942090050.USD","IE00BJT1NW94.SGD","LU1244550494.USD","SG9999014906.USD","IE00BFSS8Q28.SGD","IYH","LU0158827781.USD","LU0203201768.USD","IE00B1XK9C88.USD","LU0820561909.HKD","BK4534","LU1064131342.USD","LU0211327993.USD","LU2468319806.SGD","IE00BJLML261.HKD","SG9999015945.SGD","IE000F7OJYX1.SGD","LU1291159041.SGD","LU0256863902.USD","LU1145028129.USD","LU0238689110.USD","LU2552382058.USD","LU0795875086.SGD","LU1037948897.HKD","LU0096364046.USD","LU1712237335.SGD","LU0266013472.USD","LU2089283258.USD","LU0354030511.USD","IE00B2B36J28.USD","LU0289739343.SGD","LU0882574139.USD","IE0002270589.USD","BK4007","VHT","LU1116320901.HKD","NVO","LU1883839398.USD","LU1003077747.HKD","LU1699723380.USD","SG9999001176.SGD","ELIL","LU1691799644.USD","LU0553294199.USD","LU2125909593.SGD","MEDI","LU0306807586.USD","LLYX","LU2237443382.USD","SG9999014542.SGD","LU2361045086.USD","IE000M9KFDE8.USD","LU2552382132.HKD","LU0210536198.USD","LU0511384066.AUD","LU0477156953.USD","LU2491049909.HKD","FHLC","LU0823434740.USD","LU0889565916.HKD","LU2087625088.SGD","LU2552382215.SGD","LU0061475181.USD","IE0001KFT4U8.USD","IE00BN8TJ469.HKD","LU2112291526.USD","SG9999014898.SGD","IE00BN29S564.USD","LU1974910355.USD","LU1979441026.SGD","IE00BFXG1179.USD","LU0203345920.USD","LU1989771016.USD","LU2168564222.USD","IE00BJJMRX11.SGD","LU0109394709.USD","LU1670711123.USD","LU1623119135.USD","LU1839511570.USD","LU0868494617.USD","LU0912757837.SGD","LU0432979614.USD","LU0965509101.SGD","IE0009354923.USD","LU0122379950.USD","LU1548497426.USD","NVOX","SGXZ31699556.SGD","LU0006306889.USD","LU1232071149.USD","GNOM","LU0965508806.USD","LU2433249047.HKD","LU0203347892.USD","MHIP","MRK","IE00B19Z3581.USD","LU1585245621.USD","LU1069347547.HKD","SG9999013999.USD","IE0009355771.USD","LU2111349929.HKD","LU1066051811.HKD","LU2462591350.SGD","LU1988902786.USD","MRNY","LU2125909247.SGD","IHE","TMED","SGXZ99366536.SGD","BBH","SG9999014559.SGD","LU1093756325.SGD","LU2896262040.SGD","IE00B4R5TH58.HKD","LU0225771236.USD","LU2756315664.SGD","IE0005OL40V9.USD","MRNA","THNR","LU1261432733.SGD","LU0289961442.SGD","LU1670710588.SGD","LU0097036916.USD","LU0109391861.USD","BK4599","LU1037948541.HKD","LU1035775433.USD","LU0320765489.SGD","LU1267930730.SGD","LU0128525929.USD","LU0882574055.USD","LU0058720904.USD","LU0130102774.USD","LU0094547139.USD","LU1280957306.USD","SG9999015341.SGD","LU2746668974.SGD","LLYZ","LU1093756168.USD","LU1323610961.USD","LU0225283273.USD","LU1430594728.SGD","SG9999014575.USD","LU1670711040.USD","LU2133065610.SGD","LU0868494708.USD","LU1941712348.USD","IE00BWXC8680.SGD","LU0323591593.USD","LU1868837300.USD","SG9999015358.SGD","LU1934455194.USD","LU0198837287.USD","LU0289739699.SGD","LU0354030438.USD","LU2028103732.USD","LU2023251221.USD","LU0321505439.SGD","LU2237443978.SGD","LU0174119429.USD","LU2750360641.GBP","LU1496350171.SGD","IE00BKPKM429.USD","LU0070302665.USD","BK4588","ILDR","LU1670628061.USD","LU0079474960.USD","LU0234572021.USD","LU0859254822.USD","SG9999014880.SGD","LU1066051225.USD","SGXZ57979304.SGD","LU0985481810.HKD","LU2347655073.USD","LU1732799900.SGD","LU2129689605.HKD","LU2023250330.USD","LU2237443622.USD","LU0306806265.USD","LU0466842654.USD","HRTS","GDOC","SG9999003800.SGD","LU0786609619.USD","LU2361044865.SGD","LU0069063385.USD","LU2168564149.EUR","LU0106261372.USD","LU2357305700.SGD","LU2125154935.USD","LU1868837136.USD","IE00B775H168.HKD","ABBV","LU1162221912.USD","LU0965509283.SGD","LU1244550221.USD","IE00BVYPNW00.USD","LU0823416689.USD","LU2237443549.SGD","LU0124676726.USD","LU0345770308.USD","LU0225284248.USD","LU2756315318.SGD","LLII","LU2602419157.SGD","ELIS","IE00BKVL7J92.USD","IE00BKDWB100.SGD","LU2471134952.CNY","LU2168564065.EUR","LU2461242641.AUD","LU2242652126.USD","BK4559","LU1732800096.USD","LU2108987350.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","LU1032466523.USD","BK4585","LU2471134796.USD","IE0004445239.USD","LU0211331839.USD","LU0708995401.HKD","LU2271345857.HKD","LU0964807845.USD","LU0316494557.USD","LU1366192091.USD","LU0256863811.USD","LU1929549753.HKD","IE0000B7K699.USD","LU0472753341.HKD","LU0320765992.SGD","LU2129689514.USD","LU2237443895.HKD","LU0726765562.USD","SG9999001440.SGD","WDNA","LU1267930490.SGD","IE000SO60NU8.SGD","LU0395794307.EUR","IE00B3PB1722.GBP","LU2236285917.USD","LU1116320737.USD","LU0648001328.SGD","IE000WAW04H5.SGD","LU0708994859.HKD","BMED","LLY","LU0098860793.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU0820561818.USD","LU2491050154.USD","LU2462157665.USD","LU2491050071.SGD","IE00BSNM7G36.USD","LU1917777945.USD","IE00BFTCPJ56.SGD","RVMD","SG9999015978.USD","LU0980610538.SGD","LU1868836757.USD","LU1934455863.HKD","LU2750360997.AUD","LU2211815571.USD","LU2087621335.USD","LU2471134523.USD","LU2471134879.HKD","BK4139","LU2063271972.USD","CANC","CURE","LU0310800379.SGD","SG9999002224.SGD","BK4516","SG9999001176.USD","LU0345770993.USD","LU1629891620.HKD","MRNX","LU1069344957.HKD","IDNA","LU0385154629.USD","LU0820562030.AUD","LU1720051017.SGD","LU2129689431.USD","BK4581","LU2242646821.SGD","SG9999002232.USD","LU2168564495.EUR","IE00BLSP4239.USD","BK4566","LU2360032135.SGD","LU1670710661.SGD","SG9999015986.USD","LU2023250504.SGD","LU2596442595.SGD","BK4568","IE00B4JS1V06.HKD","LU1718418525.SGD","LU0114720955.EUR","LU2361044949.HKD","LU0133085943.USD","LU2106854487.HKD","SGXZ81514606.USD","TRUH","LU0237698245.USD","LU0154236417.USD","BMY","IE00B7KXQ091.USD","LU2168563687.JPY","PTH","LU1074936037.SGD","LU1244550577.SGD","IE00B1BXHZ80.USD","OZEM","LU2324357040.USD","LU0949170772.SGD","LGHT","PAWZ","LU0787776722.HKD","LU1720051108.HKD","FTXH","BK4551","IE0004445015.USD","IE00B42XCP33.USD","LU1989772840.SGD","LU0267386448.USD","IE00BZ1G4Q59.USD","LU2360106947.USD","LU0545039389.USD","LU2089284900.SGD","JDOC","LU1941712264.USD","IE00BLSP4452.SGD","LU0689626769.HKD","LU2746668461.USD","LU1868836591.USD","LU1061106388.HKD","LU0320765646.SGD","LU1923622614.USD","LU0320765059.SGD","LU0640476718.USD","IE000BZT7R73.USD","LU0672654240.SGD","LU1057294990.SGD","PPH","IE00BFSS7M15.SGD","GLAM","SG9999014914.USD","LU2213496289.HKD","SGXZ51526630.SGD","LU0353189763.USD","LU0823434583.USD","RXL","LU1670627923.USD","LU2264538146.SGD","SG9999015952.SGD","XLV","LU0321505868.SGD","LU0943347566.SGD","LU0661504455.SGD","LU2237438978.USD","LU0683600562.USD","IE00BK4W5L77.USD","LU0130517989.USD","IE0002141913.USD","LU0265550946.USD","LU1236620750.USD","LU2089984988.USD","IE00BDGV0183.EUR","LU0265550359.USD","LU0208291251.USD","LU0861579265.USD","LU0417517546.SGD","SG9999018865.SGD","LU0310799852.SGD","LU0738911758.USD","LU1035773651.USD","LU2265009873.SGD","LU0170899867.USD","LU0353189680.USD","LU0057025933.USD","LU0985320562.USD","LU1201861249.SGD","SG9999018857.SGD","AGNG","LU1127390331.HKD","LU1066053197.SGD","PJP","LU1868836914.USD","LU0689472784.USD","LU1236620834.HKD","GB00BDT5M118.USD","LU1267930573.SGD","SG9999017495.SGD","LU2237443465.HKD","LU1934455277.USD","LU1989772923.USD","BK4548","LU1551013342.USD","IE00BGHQF631.EUR","LU1023059063.AUD","LU1804176565.USD","BK4501","LU1066051498.USD","LU0203202063.USD","MEDX","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","PINK","IYH","BMED","MEDI","BK4588","IDNA","FRTY","RSPH","BBP","IBB","MRNY","LABU","IEIH","MRNX","TBXU","GNMX","NVIB","BK4585","SYNB","GDOC","LFSC","TECB","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","RSPH","LFSC","IBB","PINK","MEDI","BBP","SYNB","TAK","GDOC","BK4588","MRNX","LABU","IYH","TBXU","XLVX","FRTY","IEIH","MRNY","TECB","GNMX","BK4007","BMED","IDNA","PSCH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128151773","title":"India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=1128151773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128151773?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:56","pubTimestamp":1787954186,"startTime":"0","endTime":"0","summary":"India's weight-loss drug market is delivering a sobering lesson to the global pharmaceutical industry about market expectations. Despite large-scale generic production of GLP-1 medications and prices...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBDS","MEDI","NVOH","PINK","XLVI","JDOC","LLYX","UUP","NVOX","ELIS","FHLC","MNDmain","THNR","NVOC","TRUH","PJP","ELIL","CURE","FXH","UDN","OZEM","IYH","LLII","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1061106388.HKD","MEDI","BMED","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE0002270589.USD","LU0320765992.SGD","LU1057294990.SGD","LU0114720955.EUR","LU2324357040.USD","IE00B7SZLL34.SGD","LU0965508806.USD","LU1037948897.HKD","LU0859254822.USD","BK4139","LU0058720904.USD","LU1674673691.USD","LU1778281490.HKD","LU2089984988.USD","LU0965509010.AUD","LU2112291526.USD","LU1066051498.USD","BK4585","LU2357627491.SGD","LU1839511570.USD","TMED","BK4578","BK4550","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","BK4532","SG9999015952.SGD","BBH","LU2087621335.USD","BK4588","LU1430594728.SGD","LU1585245621.USD","LU0889565916.HKD","LU0289739699.SGD","SG9999015978.USD","TBXU","SG9999015945.SGD","IBBQ","LU1023059063.AUD","LU0861579265.USD","LU1066053197.SGD","LU0965509101.SGD","BK4568","BK4566","LU1037948541.HKD","LU0882574055.USD","IE00B19Z3581.USD","LU0965509283.SGD","LU1674673428.USD","LU1934455277.USD","LU1934455863.HKD","LU0234570918.USD","GILD","BIB","IE00B19Z3B42.SGD","LU1934455194.USD","LU0122379950.USD","LU0109394709.USD","LU1571399168.USD","IE00B3T34201.USD","BK4583","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663901342","title":"Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2663901342","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663901342?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:27","pubTimestamp":1787945237,"startTime":"0","endTime":"0","summary":"Eli Lilly (NYSE: LLY) received FDA approval for Mounjaro to reduce major cardiovascular risk in adults with type 2 diabetes who are at high risk.\nThe new indication expands Mounjaro’s approved use beyond blood sugar control to include cardiovascular risk reduction.\nThe decision could influence how clinicians position Mounjaro in care plans for adults with type 2 diabetes and elevated cardiovascular risk.\nPayers may factor the cardiovascular indication into future coverage and reimbursement...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-wins-fda-approval-for-mounjaro-heart-risk-redu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-wins-fda-approval-for-mounjaro-heart-risk-redu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2023250330.USD","BK4007","IE0004445239.USD","RXL","LU1691799644.USD","LU1057294990.SGD","LU1366192091.USD","LU1814569148.SGD","LU2468319806.SGD","LU1267930730.SGD","LU2237443549.SGD","LU0345770993.USD","SGXZ57979304.SGD","LLII","LU2023251221.USD","LU2271345857.HKD","LU1548497426.USD","LU2456880835.USD","LU1804176565.USD","LU1629891620.HKD","LU0289739699.SGD","LU1623119135.USD","MHIP","LU2462157665.USD","LU0672654240.SGD","LU2361045086.USD","LU0266013472.USD","IE00B4JS1V06.HKD","PJP","GB00BDT5M118.USD","LU0417517546.SGD","LU0097036916.USD","LU0094547139.USD","LU0353189680.USD","LU1712237335.SGD","LU0385154629.USD","LU2237438978.USD","LU0238689110.USD","LU2237443622.USD","LU0354030511.USD","LU2168564065.EUR","SG9999014880.SGD","LU2236285917.USD","IXJ","LU2746668974.SGD","ELIS","WDNA","LLYZ","LU1093756168.USD","IE00BKPKM429.USD","LU1061106388.HKD","LU0823434740.USD","LU0198837287.USD","LLY","LU1983299246.USD","LU0466842654.USD","SG9999015986.USD","LU0640476718.USD","LU1280957306.USD","LU2168564495.EUR","SG9999015952.SGD","PPH","THNR","LU2028103732.USD","LU2168564222.USD","TRUH","IE0002141913.USD","LU0203202063.USD","LU0079474960.USD","LU2491050071.SGD","LU2746668461.USD","IE00BN29S564.USD","SG9999001176.USD","LU0943347566.SGD","CANC","TMED","BK4599","LU2213496289.HKD","LU0471298694.HKD","LU2211815571.USD","LU1868836914.USD","IE00B4R5TH58.HKD","SGXZ81514606.USD","VHT","LU2265009873.SGD","IE00BFSS7M15.SGD","LU1868837300.USD","LU2750360641.GBP","LU2108987350.USD","LU1917777945.USD","AGNG","LU0210536198.USD","LU0256863902.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU0882574139.USD","IE00B775H168.HKD","LU2552382215.SGD","LU2237443978.SGD","LU0823434583.USD","LU2360106947.USD","ELIL","BK4533","LU2896262040.SGD","LU0109391861.USD","SG9999015945.SGD","LU1145028129.USD","LU1035775433.USD","JDOC","LU2756315664.SGD","XLV","LU2089283258.USD","LU1232071149.USD","GDOC","LU1551013425.SGD","LU2106854487.HKD","IE00BFSS8Q28.SGD","SG9999014898.SGD","LU0354030438.USD","LU0109394709.USD","LU0820561818.USD","LU1988902786.USD","LU2602419157.SGD","SGXZ31699556.SGD","SG9999013999.USD","LU2112291526.USD","LU2750360997.AUD","LU1989771016.USD","LU2168563687.JPY","SG9999001176.SGD","SGXZ99366536.SGD","LU0234572021.USD","LU0471298777.SGD","LU1720051108.HKD","LU2471134952.CNY","LU2756315318.SGD","LU0225283273.USD","IE0005OL40V9.USD","LU2552382132.HKD","LU0787776722.HKD","IE00B1BXHZ80.USD","LU0320765992.SGD","SG9999017495.SGD","MEDX","LU0106261372.USD","LU0320765059.SGD","LU1720051017.SGD","BK4534","LU1291159041.SGD","LU0882574055.USD","IE0001KFT4U8.USD","LU2491050154.USD","LLYX","BK4585","LU0432979614.USD","LU0964807845.USD","LU1127390331.HKD","LU1868836757.USD","LU1868837136.USD","OZEM","LU2237443895.HKD","LU0114720955.EUR","LU2023250504.SGD","SG9999018857.SGD","LU2087625088.SGD","LU1023059063.AUD","IE00BK4W5L77.USD","LU1093756325.SGD","CURE","LU2552382058.USD","LU2462591350.SGD","BK4588","LU1551013342.USD","IE00BK4W5M84.HKD","LU0096364046.USD","LU0353189763.USD","LU2237443465.HKD","LU1868836591.USD","IE00B1XK9C88.USD","LU1974910355.USD","LU0061475181.USD","LU0174119429.USD","LU2089984988.USD","LU0820561909.HKD","LU0683600562.USD","IE00BJT1NW94.SGD","LU1323610961.USD","FHLC","IE00BKDWB100.SGD","LU0323591593.USD","LU0786609619.USD","LU0203201768.USD","IE00BJLML261.HKD","LU1064131342.USD","LU2089284900.SGD","FTXH","LU0158827781.USD","LU2357305700.SGD","LU0689472784.USD","IE00BJJMRY28.SGD","LU1069344957.HKD","IE00BFTCPJ56.SGD","IHE","SG9999014906.USD","LU0058720904.USD","LU0820562030.AUD","SG9999015978.USD","LU2111349929.HKD","LU2264538146.SGD","HRTS","MEDI","BK4516","IYH","LU0456855351.SGD","ILDR","LU0158827948.USD","LU0708995401.HKD","IE00BWXC8680.SGD","LU0133085943.USD","SG9999014914.USD","BK4581","LU0889565916.HKD","LU1979441026.SGD","LU2417539215.USD","LU2471134796.USD","LU0006306889.USD","LU2063271972.USD","LU2168564149.EUR","LU2324357040.USD","LU2471134523.USD","IE00B7KXQ091.USD","SG9999018865.SGD","LU2361044949.HKD","LU0256863811.USD","LU0122379950.USD","LU0316494557.USD","LU2491049909.HKD","LU2471134879.HKD","IE00BJJMRX11.SGD","IE0009355771.USD","LU2237443382.USD","LU0345770308.USD","LU2361044865.SGD","LU0823416689.USD","SGXZ51526630.SGD","IE0004445015.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0859254822.USD","MEDI","LU0114720955.EUR","TBXU","LU1057294990.SGD","LU1066053197.SGD","BIB","SG9999015986.USD","LABU","IBBQ","LU0965509010.AUD","LU1934455863.HKD","BK4578","LU0109394709.USD","SG9999015978.USD","LU0823416689.USD","LU0882574055.USD","IE00B19Z3B42.SGD","GILD","LU0965509101.SGD","BMED","BK4585","TMED","LU1066051498.USD","BK4532","BK4588","IE00B19Z3581.USD","BK4566","LU1934455194.USD","LU1778281490.HKD","LU1674673691.USD","BBH","LU1037948897.HKD","IE00BSNM7G36.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","BK4139","SG9999015945.SGD","LU1934455277.USD","LU1571399168.USD","IBB","LU0889565916.HKD","LU2357627491.SGD","LU1037948541.HKD","IE00B3T34201.USD","LU0122379950.USD","IE0002270589.USD","LU2112291526.USD","LU1585245621.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662966095","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662966095","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662966095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:17","pubTimestamp":1787923054,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF  gaining by 0.1% and the iShares Biotechnology ETF  down 0.6%.Cytokinetics  shares were down 4%, extending the 1.6% loss in the previous session. The company said Friday that its phase 3 clinical trial of aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy met both primary endpoints.Hutchmed's  stock was up 1% after the company said a new drug application for fanregratinib to treat liver cancer has been granted conditional approval by China's National Medical Products Administration.Eli Lilly  stock was up 0.5% after the company said the US Food and Drug Administration approved Mounjaro to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk for those events.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1551013425.SGD","LU2237443978.SGD","MHIP","LU0417517546.SGD","LU0882574055.USD","LU0256863811.USD","LU1366192091.USD","LU0133085943.USD","LU2213496289.HKD","LU2468319806.SGD","LU0316494557.USD","VHT","BK4599","LU0320765059.SGD","LU2089984988.USD","LU0320765992.SGD","RXL","ELIL","SG9999018865.SGD","IE00BJJMRX11.SGD","LLY","LU2456880835.USD","LU0471298694.HKD","LU0238689110.USD","IE00BFSS8Q28.SGD","IE00B1XK9C88.USD","LU0432979614.USD","LU0823416689.USD","LU2361045086.USD","SG9999014914.USD","LU0058720904.USD","SGXZ81514606.USD","LU2471134796.USD","LU0353189680.USD","LU1551013342.USD","IE00B2B36J28.USD","IE00BWXC8680.SGD","LU1691799644.USD","LU0256863902.USD","LU2236285917.USD","LU0097036916.USD","LU0471298777.SGD","LU0323591593.USD","LU0353189763.USD","LU2896262040.SGD","LU1548497426.USD","LU0820561818.USD","IXJ","IE0004445015.USD","LU1983299246.USD","IE0005OL40V9.USD","LU0708995401.HKD","MEDI","IE00B1BXHZ80.USD","LU2471134879.HKD","LU2211815571.USD","LU1061106388.HKD","LU1720051108.HKD","LU2552382132.HKD","LU2361044865.SGD","LU2462157665.USD","LU2471134952.CNY","BK4139","LU0689472784.USD","IE0001KFT4U8.USD","LU2089283258.USD","LU0786609619.USD","LU0354030438.USD","TRUH","LU0266013472.USD","LU1093756325.SGD","LU2746668461.USD","LU2111349929.HKD","SG9999018857.SGD","LU2471134523.USD","LU0943347566.SGD","LU0289739699.SGD","LU1323610961.USD","FHLC","HRTS","ILDR","LU2237443895.HKD","LU2237443382.USD","LU2264538146.SGD","IE00BN29S564.USD","LU2361044949.HKD","LU2491050071.SGD","LU1988902786.USD","LU2237438978.USD","LU0234572021.USD","LU2552382215.SGD","LU1917777945.USD","OZEM","LU0683600562.USD","LU0079474960.USD","LU1093756168.USD","LU1232071149.USD","LU2271345857.HKD","SG9999014880.SGD","LU1291159041.SGD","HCM","LLYZ","IE00B4R5TH58.HKD","IE00BJJMRY28.SGD","LU1280957306.USD","LU0114720955.EUR","IE00BKPKM429.USD","LU1868836757.USD","SGXZ57979304.SGD","IE00BKDWB100.SGD","LU2168564149.EUR","IE00BK4W5M84.HKD","LU0109391861.USD","LU1267930730.SGD","LU1023059063.AUD","LU0006306889.USD","LU0158827781.USD","CANC","LU0122379950.USD","LU2168564065.EUR","LU0889565916.HKD","LU0787776722.HKD","SG9999015952.SGD","LU0456855351.SGD","BK4585","LU2552382058.USD","BK4505","LU0061475181.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","BK4588","XBI","LU1979441026.SGD","LU1868837136.USD","LU2237443622.USD","LU2746668974.SGD","SGXZ99366536.SGD","LABU","LU0820561909.HKD","LU2168563687.JPY","LU1868836914.USD","GDOC","BK4581","LU0345770993.USD","IE00B4JS1V06.HKD","LU1623119135.USD","LU1057294990.SGD","LU0094547139.USD","LU2265009873.SGD","LU0106261372.USD","LU1145028129.USD","LU2461242641.AUD","PJP","LU2023250330.USD","LU2750360641.GBP","IHE","LU1629891620.HKD","GB00BDT5M118.USD","LU2023251221.USD","LLYX","LU2756315318.SGD","LU2112291526.USD","LU0225283273.USD","LU1868836591.USD","TMED","LU0096364046.USD","LU1814569148.SGD","LU2168564222.USD","LU2357305700.SGD","IE0009355771.USD","LU0174119429.USD","LU2168564495.EUR","LU2237443549.SGD","PPH","LU2750360997.AUD","00013","LU0354030511.USD","LU1064131342.USD","LU0109394709.USD","LU0640476718.USD","LU2491049909.HKD","LU1069344957.HKD","IE00B7KXQ091.USD","LU0823434740.USD","LU0385154629.USD","LU1989771016.USD","LU1868837300.USD","LU0820562030.AUD","BK4533","LU1804176565.USD","SG9999015978.USD","BK4531","IE00B775H168.HKD","CYTK","SG9999017495.SGD","XLV","IE0004445239.USD","SG9999001176.SGD","SG9999014906.USD","LU0158827948.USD","IBB","SGXZ31699556.SGD","BK4007","LU2360106947.USD","LU2324357040.USD","BK4516","LU0345770308.USD","SG9999014898.SGD","IE00BJJMRZ35.SGD","LU1720051017.SGD","SG9999015986.USD","IE00BJLML261.HKD","LU0882574139.USD","LU2028103732.USD","IE00BFSS7M15.SGD","LU0466842654.USD","LU2237443465.HKD","LLII","SG9999013999.USD","MEDX","BK4534","LU1127390331.HKD","LU0964807845.USD","LU2108987350.USD","LU2462591350.SGD","SG9999001176.USD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","THNR","WDNA","LU1974910355.USD","CURE","LU2087625088.SGD","LU0203201768.USD","LU0210536198.USD","LU2491050154.USD","LU2106854487.HKD","LU2756315664.SGD","LU0672654240.SGD","LU1035775433.USD","LU2089284900.SGD","LU1712237335.SGD","IYH","LU0823434583.USD","JDOC","IE00BK4W5L77.USD","ELIS","SG9999015945.SGD","LU2023250504.SGD","FTXH","LU0198837287.USD","LU2602419157.SGD","LU2063271972.USD","AGNG","LU0203202063.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662953510","title":"Rhythm Pharmaceuticals Initiated at Hold by Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2662953510","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662953510?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:09","pubTimestamp":1787922540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RYTM/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4552","MEDI","RYTM","BK4139","BK4118","DB","BK4566","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062924","title":"Rhythm Pharmaceuticals, Inc. : Deutsche Bank Initiates Coverage with Hold Rating and Target Price $120","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062924?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:09","pubTimestamp":1787915342,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nAQN2MGYV2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RYTM","MEDI","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}